Please login to the form below

Not currently logged in
Email:
Password:

Sanofi and Audion in hearing partnership

Sanofi has entered into a two-year research collaboration with the Audion Therapeutics to develop potential treatments for hearing loss

Sanofi has entered into a two-year research collaboration with the Audion Therapeutics to develop potential treatments for hearing loss through the optimisation of small molecules by using a regenerative medicine approach.

The research will use technology developed at the Massachusetts Eye and Ear Infirmary in the Eaton-Peabody Laboratory, a basic research facility dedicated to the study of hearing and deafness, by investigator and Audion co-founder Dr Albert Edge, who has strong expertise in stem cells and inner ear biology. Audion licensed Dr Edge's technology from Mass Eye and Ear. 

Under the terms of the agreement, Sanofi has an option to license technology rights from Audion related to research conducted under the collaboration.

<

Dr Elias Zerhouni, president of global R&D at Sanofi, said: "Our new relationship with Audion demonstrates our commitment to work with partners on conditions with unmet and growing medical needs, such as hearing loss.

"This collaboration is a multi-disciplinary approach with our internal Aging Therapeutic Strategic Unit and our Early-to-Candidate Unit working together to advance novel therapies in the field of otolaryngology using the most advanced technologies available to study cochlear biology," he added.

16th June 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...